TRICYCLIC COMPOUNDS USEFUL AS OXYTOCIN RECEPTOR AGONISTS

Methods for treating and preventing anxiety, anxiety-related disorders, schizophrenia and schizophrenia-related disorders are described herein wherein said methods comprise the administration of oxytocin receptor agonists.

Saved in:
Bibliographic Details
Main Authors RESNICK, LYNN, RING, ROBERT H, ROSENZWEIG-LIPSON, SHARON JOY, RAHMAN, ZIA
Format Patent
LanguageEnglish
French
Published 03.05.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Methods for treating and preventing anxiety, anxiety-related disorders, schizophrenia and schizophrenia-related disorders are described herein wherein said methods comprise the administration of oxytocin receptor agonists.
AbstractList Methods for treating and preventing anxiety, anxiety-related disorders, schizophrenia and schizophrenia-related disorders are described herein wherein said methods comprise the administration of oxytocin receptor agonists.
Author RESNICK, LYNN
RAHMAN, ZIA
ROSENZWEIG-LIPSON, SHARON JOY
RING, ROBERT H
Author_xml – fullname: RESNICK, LYNN
– fullname: RING, ROBERT H
– fullname: ROSENZWEIG-LIPSON, SHARON JOY
– fullname: RAHMAN, ZIA
BookMark eNrjYmDJy89L5WSwCAnydI509vF0VnD29w3wD_VzCVYIDXZ1C_VRcAxW8I-IDPF39vRTCHJ1dg0I8Q9ScHT39_MMDgnmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo5GZkZmhhYGjobGRCgBAEkuKiQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate METHODES DE TRAITEMENT UTILISANT DES AGONISTES DU RECEPTEUR D'OXYTOCINE
ExternalDocumentID CA2626180A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2626180A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:53:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2626180A13
Notes Application Number: CA20062626180
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070503&DB=EPODOC&CC=CA&NR=2626180A1
ParticipantIDs epo_espacenet_CA2626180A1
PublicationCentury 2000
PublicationDate 20070503
PublicationDateYYYYMMDD 2007-05-03
PublicationDate_xml – month: 05
  year: 2007
  text: 20070503
  day: 03
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies WYETH
RelatedCompanies_xml – name: WYETH
Score 2.6720693
Snippet Methods for treating and preventing anxiety, anxiety-related disorders, schizophrenia and schizophrenia-related disorders are described herein wherein said...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title TRICYCLIC COMPOUNDS USEFUL AS OXYTOCIN RECEPTOR AGONISTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070503&DB=EPODOC&locale=&CC=CA&NR=2626180A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401ag3rRrrK3sw3IjQwlIOxNAFLKZlCQ_TnhrAbdILbSzGv--AbfWit81uMpmd5Nv5ZnZnFuABGaxi5AMhZ6auy5qRKbJZ5IasCir66luR5WZdOzwJ6CjVXqb6tAXLXS1M0yf0s2mOiIgqEO9Vc16vf5JYTvO2cvOYL3Fq9eQlliPtomOjbm8iOUPLDbnDmcSYxWwpiKweEnd1oNgYKB0gizZqMLivw7ooZf3bo3incBiisLI6g5YoO3DMdh-vdeBosr3vxuEWeptzGCSRz2Zs7DPC-CTkaeDEJI1dLx0TOyZ8Oks48wMSucwNEx4R-5kHfpzEF0A8N2EjGVWY77c7Z_Ze2f4ltMtVKa6ALLRevtAKlWYYR1ITeYNOhch1ikY2qap2ofunmOt_1m7g5DtdqctK_xba1fuHuEM_W-X3jYW-ABs-fFE
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFH9ZpnHedGqcnz0YbkTYoIwDMayAQ4ESPsx2WoB1yS5scRj_fQtu04vemjZ5eX3Jr--jfb8CPPAIVtLyIRMzXVVFRcskUS9yTZQZZgN5XmS5XvcO-wEep8rLRJ20YLnrhWl4Qj8bckSOqILjvWrO6_VPEctq3lZuHvMln1o9OYlhCbvsWKvpTQRrZNghtSgRCDGIKQSR0eeBuzyUTJ4oHXD9tBoM9tuobkpZ__YozgkchlxYWZ1Ci5Vd6JDdx2tdOPK39918uIXe5gyGSeSSKfFcggj1Q5oGVozS2HZSD5kxopNpQokboMgmdpjQCJnPNHDjJD4H5NgJGYtchdl-uzNi7pUdXEC7XJXsEtBC6ecLpZBxxvNIrPO4QcWM5SrmRtaxLPeg96eYq3_W7qEzTnxv5rnB6zUcf5cuVVEa3EC7ev9gt9znVvldY60vGxh_RA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TRICYCLIC+COMPOUNDS+USEFUL+AS+OXYTOCIN+RECEPTOR+AGONISTS&rft.inventor=RESNICK%2C+LYNN&rft.inventor=RING%2C+ROBERT+H&rft.inventor=ROSENZWEIG-LIPSON%2C+SHARON+JOY&rft.inventor=RAHMAN%2C+ZIA&rft.date=2007-05-03&rft.externalDBID=A1&rft.externalDocID=CA2626180A1